You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • OP0094 Cost-Effectiveness of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: 2-Year Results of the Randomised Controlled Swefot Trial

Citation Tools

Article menu
Download PDFPDF
Oral Presentations
Abstract session: Epidemiology: outcomes
OP0094 Cost-Effectiveness of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: 2-Year Results of the Randomised Controlled Swefot Trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Eriksson J, Karlsson JA, Bratt J, et al
OP0094 Cost-Effectiveness of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: 2-Year Results of the Randomised Controlled Swefot Trial
Annals of the Rheumatic Diseases 2013;72:A82.